- EXCLUSIVE OFFER: Jim Cramer's Protégé, Dave Peltier, only buys Stocks Under $10 that he thinks could potentially double. See what he's trading today with a 14-day FREE pass.
- You can view the full Pfizer Ratings Report.
Pfizer is working on its eighth straight loss after failing near heavy resistance.
Shares of Pfizer have been on the decline, losing some 5% from its January 5 high of $33.61 a share.
CoLucid will be acquired for $46.50 per share, a 33% premium to the stock's closing price Tuesday.
The $101 billion market cap pharma could be put in play or targeted by an activist investor soon.